AI Maverick Intel Inc. (OTC: AIMV) announced the issuance of 76.5 million common shares to HEAL Group Holdings as the initial tranche of consideration under the companies’ Right of First Refusal Agreement dated Feb. 11, 2026, advancing its proposed acquisition of HEAL Access Canada Inc. The total consideration has been adjusted from 120 million to 100 million AIMV common shares, with the parties continuing toward a definitive agreement. The company also noted plans to pursue an uplisting to the OTCQB Venture Market as part of its broader capital markets strategy.
This transaction underscores AI Maverick Intel’s focus on identifying and developing opportunities at the intersection of artificial intelligence, data platforms, and emerging technology-enabled industries. The company evaluates strategic acquisitions, partnerships, and scalable platforms designed to drive long-term shareholder value. The acquisition of HEAL Access Canada, a healthcare access platform, aligns with this vision, potentially expanding AIMV’s footprint in AI-driven healthcare solutions.
The issuance of the initial shares and the adjusted consideration reflect ongoing negotiations and due diligence. For investors, this milestone signals progress toward a definitive agreement, which could unlock synergies in AI and healthcare. The planned uplisting to OTCQB, a higher tier of the over-the-counter markets, may enhance liquidity and visibility for AIMV shares, attracting a broader investor base.
AI Maverick Intel’s strategy involves leveraging artificial intelligence to transform industries. By acquiring HEAL Access Canada, the company aims to integrate AI capabilities into healthcare access, potentially improving patient outcomes and operational efficiencies. The healthcare sector has increasingly adopted AI for diagnostics, telemedicine, and administrative tasks, and this acquisition positions AIMV to capitalize on these trends.
Investors should monitor the progression toward a definitive agreement and the completion of the uplisting. The latest news and updates relating to AIMV are available in the company’s newsroom at http://ibn.fm/AIMV. The full press release can be viewed at https://ibn.fm/mivWz.
The transaction highlights AIMV’s commitment to expanding its AI portfolio through strategic acquisitions. As the company works toward finalizing the deal and achieving an OTCQB uplisting, it aims to create long-term value for shareholders while advancing AI applications in healthcare.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is AI Maverick Intel Issues Initial Shares for HEAL Access Canada Acquisition, Adjusts Consideration.